19668 Federal Register / Vol. 87, No. 65 / Tuesday, April 5, 2022 / Notices 

considered during the 5-year review and 

in any related follow-up actions (if 

warranted) and may also be used in 

evaluating ongoing research and 

management of Atlantic HMS. 

Authority: 16 U.S.C. 1801 et seq. 

Dated: March 31, 2022. 

Ngagne Jafnar Gueye, 

Acting Director, Office of Sustainable 

Fisheries, National Marine Fisheries Service. 

[FR Doc. 2022–07167 Filed 4–4–22; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF COMMERCE 

National Oceanic and Atmospheric 

Administration 

[RTID 0648–XB906] 

South Atlantic Fishery Management 

Council; Public Meetings 

AGENCY: National Marine Fisheries 

Service (NMFS), National Oceanic and 

Atmospheric Administration (NOAA), 

Commerce. 

ACTION: Notice of a public meeting. 

SUMMARY: The South Atlantic Fishery 

Management Council (Council) will 

hold a meeting of the Dolphin Wahoo 

Advisory Panel (AP) on April 20 and 21, 

2022. 

DATES: The Dolphin Wahoo AP meeting 

will be held April 20–21, 2022. The 

meeting will be held from 1:30 p.m. 

until 5 p.m. EDT on April 20th and from 

9 a.m. until 12 p.m. EDT on April 21st. 

ADDRESSES: 

Meeting address: The meeting will be 

held at the Crowne Plaza Hotel, 4831 

Tanger Outlet Blvd., N Charleston, SC 

29418; phone: (883) 744–4422. 

Council address: South Atlantic 

Fishery Management Council, 4055 

Faber Place Drive, Suite 201, N 

Charleston, SC 29405. 

The meeting will also be available via 

webinar. Registration is required. 

Webinar registration, an online public 

comment form, and briefing book 

materials will be available two weeks 

prior to the meeting at: https://

safmc.net/safmc-meetings/currentadvisory-panel-meetings/. 

FOR FURTHER INFORMATION CONTACT: John 

Hadley, Fishery Management Plan 

Coordinator, SAFMC; phone: (843) 571– 

4366 or toll free: (866) SAFMC–10; fax: 

(843) 769–4520; email: john.hadley@

safmc.net. 

SUPPLEMENTARY INFORMATION: Agenda 

items for the Dolphin Wahoo AP 

meeting include: Review of recent and 

developing Council actions; review of 

draft Framework Amendment 2 to the 

Dolphin Wahoo Fishery Management 

Plan that would extend the applicable 

range of the minimum size limit, modify 

recreational retention limits, and reduce 

or remove captain and crew bag limits 

for dolphin; input on the potential need 

for regional management and other 

future management changes; and an 

update of the fishery performance report 

for dolphin. The AP will also receive 

updates on the Council’s Citizen 

Science Program, the Climate Change 

Scenario Workgroup, and address other 

business. The AP will provide 

recommendations for Council 

consideration as appropriate. 

Special Accommodations 

The meeting is physically accessible 

to people with disabilities. Requests for 

auxiliary aids should be directed to the 

Council office (see ADDRESSES) 5 days 

prior to the meeting. 

Note: The times and sequence specified in 

this agenda are subject to change. 

Authority: 16 U.S.C. 1801 et seq. 

Dated: March 31, 2022. 

Tracey L. Thompson, 

Acting Deputy Director, Office of Sustainable 

Fisheries, National Marine Fisheries Service. 

[FR Doc. 2022–07120 Filed 4–4–22; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Uniform Formulary Beneficiary 

Advisory Panel; Notice of Federal 

Advisory Committee meeting 

AGENCY: Under Secretary of Defense for 

Personnel and Readiness, Department of 

Defense (DoD). 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The DoD is publishing this 

notice to announce that the following 

Federal Advisory Committee meeting of 

the Uniform Formulary Beneficiary 

Advisory Panel (UF BAP) will take 

place. 

DATES: Open to the public Wednesday, 

April 6, 2022, 10:00 a.m.–1:00 p.m. 

(Eastern Standard Time). 

ADDRESSES: The meeting will be held 

telephonically or via conference call. 

The phone number for the remote access 

on April 6, 2022 is: CONUS: 1–800– 

369–2046; OCONUS: 1–203–827–7030; 

PARTICIPANT CODE: 8546285. 

These numbers and the dial-in 

instructions will also be posted on the 

Uniform Formulary Beneficiary 

Advisory Panel Website at: https://

www.health.mil/Military-Health-Topics/ 

Access-Cost-Quality-and-Safety/ 

Pharmacy-Operations/BAP. 

FOR FURTHER INFORMATION CONTACT: 

Designated Federal Official (DFO) 

Colonel Paul J. Hoerner, USAF, 703– 

681–2890 (voice), dha.ncr.j6.mbx.baprequests@mail.mil (email). 

Mailing address is 7700 Arlington 

Boulevard, Suite 5101, Falls Church, VA 

22042–5101. Website: https://

www.health.mil/Military-Health-Topics/ 

Access-Cost-Quality-and-Safety/ 

Pharmacy-Operations/BAP. The most 

up-to-date changes to the meeting 

agenda can be found on the website. 

SUPPLEMENTARY INFORMATION: Due to 

circumstances beyond the control of the 

DoD and the DFO, the UF BAP was 

unable to provide public notification 

required by 41 CFR 102–3.150(a) 

concerning its April 6, 2022 meeting of 

the UF BAP. Accordingly, the Advisory 

Committee Management Officer for the 

DoD, pursuant to 41 CFR 102–3.150(b), 

waives the 15-calendar day notification 

requirement. 

This meeting is being held under the 

provisions of the Federal Advisory 

Committee Act (FACA) (5 U.S.C., 

appendix) and 41 CFR 102–3.140 and 

102–3.150. 

Purpose of the Meeting: The Panel 

will review and comment on 

recommendations made to the Director, 

Defense Health Agency, by the 

Pharmacy and Therapeutics Committee, 

regarding the Uniform Formulary. 

Agenda 

1. 10:00 a.m.–10:10 a.m. Sign In for UF BAP 

members 

2. 10:10 a.m.–10:40 a.m. Welcome and 

Opening Remarks 

a. Welcome, Opening Remarks, and 

Introduction of UF BAP Members by Col 

Paul J. Hoerner, DFO, UF BAP 

b. Opening Remarks by UF BAP Co-Chair 

Senior Chief Petty Officer Jon R. 

Ostrowski, Non-Commissioned Officers 

Association 

c. Introductory Remarks by CDR Scott 

Raisor, Interim Chief, Formulary 

Management Branch 

d. Public Written Comments by CDR Raisor 

3. 10:40 a.m.–11:45 a.m. Scheduled 

Therapeutic Class Reviews 

a. Oncological Agents: Renal Cell 

Carcinoma; Myelofibrosis; Epidermal 

Growth Factor Receptor (EGFR) plus 

Non-Small Cell Lung Cancer (NSCLC); 

Non-Bruton’s Tyrosine Kinase Inhibitor 

(Non-BTKI) for Chronic Lymphocytic 

Leukemia (CLL)/Small Lymphocytic 

Lymphoma (SLL); and Poly Adenosine 

Diphosphate-Ribose (PARP) Inhibitors 

subclasses 

b. Binders-Chelators-Antidotes-Overdose 

Agents: Hypoglycemia Agents 

4. 11:45 a.m.–12:30 p.m. Newly Approved 

Drugs Review 

5. 12:30 p.m.–12:45 p.m. Pertinent 


jspears on DSK121TN23PROD with NOTICES1